Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial

2017 ◽  
Vol 55 (3) ◽  
pp. 295-299 ◽  
Author(s):  
Nicoletta Musacchio ◽  
◽  
Ilaria Ciullo ◽  
Marco Scardapane ◽  
Annalisa Giancaterini ◽  
...  
2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Patricia Sunaert ◽  
Hilde Bastiaens ◽  
Luc Feyen ◽  
Boris Snauwaert ◽  
Frank Nobels ◽  
...  

2016 ◽  
Vol 8 (1) ◽  
Author(s):  
Deise Regina Baptista ◽  
Astrid Wiens ◽  
Roberto Pontarolo ◽  
Lara Regis ◽  
Walleri Christine Torelli Reis ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Jing-Xia Kong ◽  
Lin Zhu ◽  
Hong-Mei Wang ◽  
Ying Li ◽  
An-Ying Guo ◽  
...  

Objective. The Chronic Care Model, based on core elements of team-centered care in chronic diseases, has widely been accepted. This study was aimed at evaluating the effectiveness of the Chronic Care Model in type 2 diabetes management. Methods. A group randomized experimental study was conducted. Twelve communities of the Zhaohui Community Health Service Center in Hangzhou, China, were randomly assigned into an intervention group (n=6) receiving the Chronic Care Model-based intervention and a control group (n=6) receiving conventional care. A total of three hundred patients, twenty-five for each community, aged ≥18 years with type 2 diabetes for at least 1-year duration, were recruited. Data of health behaviors, clinical outcomes, and health-related quality of life (Short-Form 36-item questionnaire) were collected before and after a 9-month intervention and analyzed using descriptive statistics, t-test, chi-square test, binary logistic regression, and linear mixed regression. A total of 258 patients (134 in intervention and 124 in control) who completed the baseline and follow-up evaluations and the entire intervention were included in the final analyses. Results. Health behaviors such as drinking habit (OR=0.07, 95% CI: 0.01, 0.75), physical activity (OR=2.92, 95% CI: 1.18, 7.25), and diet habit (OR=4.30, 95% CI: 1.49, 12.43) were improved. The intervention group had a remarkable reduction in glycated hemoglobin (from 7.17% to 6.60%, P<0.001). The quality of life score changes of the role limitation due to physical problems (mean=9.97, 95% CI: 3.33, 16.60), social functioning (mean=6.50, 95% CI: 2.37, 10.64), role limitation due to emotional problems (mean=8.06, 95% CI: 2.15, 13.96), and physical component summary score (mean=3.31, 95% CI: 1.22, 5.39) were improved in the intervention group compared to the control group. Conclusion. The Chronic Care Model-based intervention helped improve some health behaviors, clinical outcomes, and quality of life of type 2 diabetes patients in China in a short term.


2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Patricia Sunaert ◽  
Hilde Bastiaens ◽  
Frank Nobels ◽  
Luc Feyen ◽  
Geert Verbeke ◽  
...  

2011 ◽  
Vol 28 (6) ◽  
pp. 724-730 ◽  
Author(s):  
N. Musacchio ◽  
A. Lovagnini Scher ◽  
A. Giancaterini ◽  
L. Pessina ◽  
G. Salis ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (7) ◽  
pp. e036202
Author(s):  
Loise Ng'ang'a ◽  
Gedeon Ngoga ◽  
Symaque Dusabeyezu ◽  
Bethany L Hedt-Gauthier ◽  
Patient Ngamije ◽  
...  

IntroductionMost patients diagnosed with diabetes in sub-Saharan Africa (SSA) present with poorly controlled blood glucose, which is associated with increased risks of complications and greater financial burden on both the patients and health systems. Insulin-dependent patients with diabetes in SSA lack appropriate home-based monitoring technology to inform themselves and clinicians of the daily fluctuations in blood glucose. Without sufficient home-based data, insulin adjustments are not data driven and adopting individual behavioural change for glucose control in SSA does not have a systematic path towards improvement.Methods and analysisThis study explores the feasibility and impact of implementing self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes in rural Rwandan districts. This is an open randomised controlled trial comprising of two arms: (1) Intervention group—participants will receive a glucose metre, blood test strips, logbook, waste management box and training on how to conduct SMBG in additional to usual care and (2) Control group—participants will receive usual care, comprising of clinical consultations and routine monthly follow-up. We will conduct qualitative interviews at enrolment and at the end of the study to assess knowledge of diabetes. At the end of the study period, we will interview clinicians and participants to assess the perceived usefulness, facilitators and barriers of SMBG. The primary outcomes are change in haemoglobin A1c, fidelity to SMBG protocol by patients, appropriateness and adverse effects resulting from SMBG. Secondary outcomes include reliability and acceptability of SMBG and change in the quality of life of the participants.Ethics and disseminationThis study has been approved by the Rwanda National Ethics Committee (Kigali, Rwanda No.102/RNEC/2018). We will disseminate the findings of this study through presentations within our study settings, scientific conferences and publication in a peer-reviewed journal.Trial registration numberPACTR201905538846394; pre-results.


Sign in / Sign up

Export Citation Format

Share Document